Molecular Analysis of Local Relapse in High-Risk Breast Cancer Patients
Author Information
Author(s): Koukourakis M I, Giatromanolaki A, Galazios G, Sivridis E
Primary Institution: Democritus University of Thrace
Hypothesis
Can radiotherapy fractionation and time factors make a difference in local relapse rates for high-risk breast cancer patients?
Conclusion
The study found that specific molecular features are linked to high local relapse rates, which can be mitigated by using large radiotherapy fractions and treatment acceleration.
Supporting Evidence
- Adjuvant radiotherapy significantly improves local control rates in aggressive breast cancer patients.
- High angiogenesis predicts a high rate of local relapse independent of the radiotherapy scheme.
- Patients treated with HypoARC had better local relapse-free survival compared to those treated with conventional radiotherapy.
Takeaway
This study looked at breast cancer patients and found that certain tumor characteristics can lead to more relapses after treatment, but changing how radiation is given can help reduce this risk.
Methodology
The study involved 72 high-risk breast cancer patients treated with surgery, chemotherapy, and a specific radiotherapy regimen, with follow-up to assess local relapse rates.
Potential Biases
Potential biases may arise from the selection of patients and the retrospective nature of some analyses.
Limitations
The study had a relatively limited number of patients and focused on high-risk cases, which may not be generalizable.
Participant Demographics
Patients were high-risk breast cancer patients with aggressive tumor features, including large primary tumors and extensive node involvement.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website